9:22 AM
Leo Group India
| ||
| Pharmaceutical Export Promotion Council of India seeks clarity from US on new ... Economic Times Pharmexcil has sought clarity from the United States Food and Drug Administration (USFDA ) on the new generic drug user fee norms. See all stories on this topic » | ||
| Auxilium Pharmaceuticals, Inc. to Present At The JMP Securities 2012 ... MarketWatch (press release) About Auxilium Auxilium Pharmaceuticals, Inc. is a specialty biopharmaceutical company with a focus on developing and marketing products to predominantly specialist audiences. Auxilium markets Testim® 1% (testosterone gel) for the topical treatment of ... See all stories on this topic » | ||
| India moves closer to rolling out 'drugs for all' plan Economic Times India is moving ahead with ambitious plans to spend nearly $5 billion to supply free drugs to patients -- bringing the nation closer to universal health coverage. See all stories on this topic » | ||
| Pharmexcil asks for clarity from US Regulator on generic drug fee norms Economic Times The Pharmaceutical Export Promotion Council of India (Pharmexcil) has sought clarity from the United States Food and Drug Administration (USFDA) on the new generic drug user fee norms. See all stories on this topic » | ||
| Aoxing Pharmaceutical Company Announces Management Change Sacramento Bee PRNewswire/ -- Aoxing Pharmaceutical Company, Inc. (NYSEAMEX: AXN), a specialty pharmaceutical company specializing in research, development, manufacturing and distribution of a range of narcotics and pain-management products, today announced ... See all stories on this topic » | ||
| Sucampo Pharmaceuticals Announces Arbitration Decision MarketWatch (press release) BETHESDA, Md., Jul 06, 2012 (BUSINESS WIRE) -- Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) today announced that it has received a final binding decision on its claims in the dispute with its partner, Takeda Pharmaceutical Company Limited. See all stories on this topic » | ||
| Generic drugs are only source of deliverance for most people Deccan Herald When the Government of India recently authorised an Indian pharmaceutical company to manufacture the generic version of a cancer drug owned and patented by a multinational giant, it unleashed a host of angry responses from those whose commercial ... See all stories on this topic » | ||
| Restricting FDI in domestic pharmaceutical companies makes no sense Economic Times New onerous restrictions on foreign buyouts of domestic drug companies threaten the health of the entire Indian pharma sector. See all stories on this topic » | ||
| Sucampo seeks Takeda talks after losing legal battle Reuters India (Reuters) - U.S. drugmaker Sucampo Pharmaceuticals is seeking talks with marketing partner Takeda Pharmaceutical Co Ltd to mend their relationship, after losing a two-year legal battle to sever ties with. See all stories on this topic » | ||
| R-Tech Ueno, Ltd. Announces Result of Arbitration Against Takeda ... MarketWatch (press release) We aim at becoming a "global pharmaceutical company specializing in specific fields (ophthalmology and dermatology) and developing and selling pharmaceutical products through the eyes of doctors." We are promoting the development of new drugs for ... See all stories on this topic » |
Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment